SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-19-002458
Filing Date
2019-04-22
Accepted
2019-04-22 16:15:52
Documents
4
Period of Report
2019-06-04
Effectiveness Date
2019-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2238509zdef14a.htm DEF 14A 348144
2 G102608.JPG g102608.jpg GRAPHIC 5386
3 G26122BGI001.GIF g26122bgi001.gif GRAPHIC 123959
4 G26122BGI002.GIF g26122bgi002.gif GRAPHIC 111189
  Complete submission text file 0001047469-19-002458.txt   680787
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37467 | Film No.: 19759584
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1